Anatol P, Robert F, Danuta P. Effect of interferon alpha2b plus ribavirin treatment on selected growth factors in respect to inflammation and fibrosis in chronic hepatitis C. World J Gastroenterol 2005; 11(12): 1854-1858 [PMID: 15793880 DOI: 10.3748/wjg.v11.i12.1854]
Corresponding Author of This Article
Dr. Panasiuk Anatol, M.D., Department of Infectious Diseases, Medical University of Białystok, 15-540 Białystok, Zurawia str., 14, Poland. anatol@panasiuk.pl
Article-Type of This Article
Brief Reports
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Table 4 Serum concentrations of GF in virological responders and non-responders, Student’s t test (mean±SD).
Growth factor
Responders
Non-responders
P
0 wk
48 wk
0 wk
48 wk
0 wk
48 wk
HGF (pg/mL)
873±210
792±198
919±257
742±260
0.6
0.7
EGF (pg/mL)
16.8±5.8
16.1±6.2
20.4±8.4
15.5±4.9
0.2
0.8
TPO (pg/mL)
48.4±14
68.8±13
64.2±17.1
54.8±12
0.03
0.2
PDGF (pg/mL)
425±111
292±180
340±111
377±98
0.1
0.1
Table 5 Correlation of GF in the course of IFNα2b with RBV therapy with grade activity of inflammation and fibrosis in the liver in responders (R) and non-responders (NR). Histological classification according to Scheuer[13].
Growth factor
Inflammation activity, grading
Fibrosis hepatitis,staging
Periportal
Intralobular
HGF
R
NR
r = 0.4, P<0.05
r = 0.5, P<0.05
NS
NS
r = 0.5, P<0.03
r = 0.4, P<0.03
EGF
R
r=–0.6, P<0.003
r = –0.5, P<0.01
NS
NR
NS
NS
NS
TPO
R
r=0.5, P<0.01
r = 0.6, P<0.004
r = 0.5, P<0.01
NR
NS
NS
r = 0.4, P<0.04
PDGF
R
r=–0.5, P<0.01
r = –0.5, P<0.02
NS
NR
NS
NS
NS
Citation: Anatol P, Robert F, Danuta P. Effect of interferon alpha2b plus ribavirin treatment on selected growth factors in respect to inflammation and fibrosis in chronic hepatitis C. World J Gastroenterol 2005; 11(12): 1854-1858